At the conclusion of the Week 2 football schedule, all 11 Section 2 Class A teams had at least one loss. Many of the teams considered among the best in the classification stood at 0-2. Three weeks ...

Another week of the 2025-26 NFL regular season is in the books, with the Dallas Cowboys coming away with a huge win over the New York Jets. It was the team's most impressive game of the season, with ...

Funding will fuel the growth of eWitness, Unit 221B's invite-only platform that empowers threat hunters to disrupt online criminal gangs and speed up the investigative process Cybercrime is growing ...

Fraction and Aja collaboration in this seminal series created some of the most memorable stories, scenes, and one-liners in modern comics. The first issue immediately sets the stage for the entire run ...

Hemp already has a good reputation for use in medicine. As a member of the same species as the marijuana plant, Cannabis sativa, hemp contains cannabidiol—a compound more commonly known as CBD. By ...

The NFL’s Week 4 action left more than just wins and losses on the scoreboard. Several teams lost star players to devastating injuries, forcing oddsmakers and analysts to quickly rethink their outlook ...

New Delhi: In a quiet hall at the India International Centre, the air suddenly filled with the sound of palms striking in unison, ‘clap, clap, clap’. Padma Shri awardee and renowned Kathak exponent ...

Wilson declined to ask for his release. He told reporters this past Wednesday that he would serve as a mentor for Dart, saying, "I know that I'm going to respond in the right way every day." Wilson ...

Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may help stem the epidemic 40 years after it began. By Apoorva Mandavilli A ...

Detroit, MI, Sept. 23, 2025 (GLOBE NEWSWIRE) — The College for Creative Studies (CCS), a leading institution in art and design education, today announced the launch of a new Bachelor of Arts in ...

Following after is AXS-12 (reboxetine) for narcolepsy, which could be filed in 2023. In addition to its pipeline candidates, Axsome also has US rights to Jazz Pharma's dual-acting dopamine and ...